CJC is published 12 times a year.
Sign up for Table of Contents Alerts!
Please note: CJC is published in English and Chinese. Manuscripts are published online prior to printing. The citation will change as volume, issue and page numbers are finalized.
Email this page
Print this page
Commentary
Molecular Target Therapy: A Milestone on the Road for Curing Cancer
Yi-Xin Zeng, Xiao-shi Zhang and Quentin Liu
volume 27 | issue 8
August 2008Pages: 99 - 101
Subscribe to this journal for $0/year
Molecular target therapy (MTT), using chemicals of low molecular weight, monoclonal antibodies, and/or polypeptides to interfere with specific signal pathways in cancer cells, causes inhibition of tumor progression. Clinical evidence has demonstrated that MTT has promising potential in not only killing tumors but also inducing tumor cells differentiate into normal cells, leading to cure of the patients. Furthermore, MTT leads to potent inhibition of oncogenic signals. The delay of tumor progression makes the patients “survival with tumor”. Thus, in the future it is possible that cancer become a chronic disease much like diabetes and hypertension. This article reviewed the theory on molecular target therapy, its features and future direction.
Authors
Yi-Xin Zeng
State Key Laboratory of Oncology in South China; and Sun Yat-sen University Cancer Center
Xiao-shi Zhang
State Key Laboratory of Oncology in South China; and Sun Yat-sen University Cancer Center
Quentin Liu
State Key Laboratory of Oncology in South China; and Sun Yat-sen University